CRL Annual Retained Earnings
$1.89 B
+$454.32 M+31.71%
30 December 2023
Summary:
As of January 21, 2025, CRL annual retained earnings is $1.89 billion, with the most recent change of +$454.32 million (+31.71%) on December 30, 2023. During the last 3 years, it has risen by +$1.26 billion (+201.75%). CRL annual retained earnings is now at all-time high.CRL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Retained Earnings
$2.12 B
+$69.28 M+3.37%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly retained earnings is $2.12 billion, with the most recent change of +$69.28 million (+3.37%) on September 28, 2024. Over the past year, it has increased by +$235.62 million (+12.48%). CRL quarterly retained earnings is now at all-time high.CRL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +31.7% | +12.5% |
3 y3 years | +201.8% | +12.5% |
5 y5 years | +4383.1% | +12.5% |
CRL Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +92.4% | at high | +116.5% |
5 y | 5-year | at high | +573.2% | at high | +657.3% |
alltime | all time | at high | +428.1% | at high | +469.1% |
Charles River Laboratories International Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.12 B(+3.4%) |
June 2024 | - | $2.05 B(+4.8%) |
Mar 2024 | - | $1.96 B(+3.8%) |
Dec 2023 | $1.89 B(+31.7%) | $1.89 B(+9.7%) |
Sept 2023 | - | $1.72 B(+5.4%) |
June 2023 | - | $1.63 B(+6.3%) |
Mar 2023 | - | $1.54 B(+7.2%) |
Dec 2022 | $1.43 B(+46.1%) | $1.43 B(+12.0%) |
Sept 2022 | - | $1.28 B(+8.2%) |
June 2022 | - | $1.18 B(+10.2%) |
Mar 2022 | - | $1.07 B(+9.5%) |
Dec 2021 | $980.75 M(+56.8%) | $980.75 M(+11.6%) |
Sept 2021 | - | $878.82 M(+13.3%) |
June 2021 | - | $775.39 M(+12.9%) |
Mar 2021 | - | $686.94 M(+9.8%) |
Dec 2020 | $625.41 M(+123.1%) | $625.41 M(+24.7%) |
Sept 2020 | - | $501.44 M(+25.8%) |
June 2020 | - | $398.53 M(+20.4%) |
Mar 2020 | - | $331.10 M(+18.1%) |
Dec 2019 | $280.33 M(+565.9%) | $280.33 M(+31.1%) |
Sept 2019 | - | $213.77 M(+51.7%) |
June 2019 | - | $140.96 M(+45.0%) |
Mar 2019 | - | $97.23 M(+131.0%) |
Dec 2018 | $42.10 M(-85.4%) | $42.10 M(-90.9%) |
Sept 2018 | - | $460.12 M(+15.1%) |
June 2018 | - | $399.75 M(+15.5%) |
Mar 2018 | - | $346.04 M(+19.9%) |
Dec 2017 | $288.66 M(+74.6%) | $288.66 M(-9.4%) |
Sept 2017 | - | $318.51 M(+19.7%) |
June 2017 | - | $266.03 M(+25.4%) |
Mar 2017 | - | $212.08 M(+28.3%) |
Dec 2016 | $165.30 M(+1468.6%) | $165.30 M(+37.0%) |
Sept 2016 | - | $120.62 M(+45.5%) |
June 2016 | - | $82.89 M(+73.8%) |
Mar 2016 | - | $47.68 M(+352.5%) |
Dec 2015 | $10.54 M(-107.6%) | $10.54 M(-149.4%) |
Sept 2015 | - | -$21.35 M(-63.7%) |
June 2015 | - | -$58.73 M(-45.2%) |
Mar 2015 | - | -$107.23 M(-22.7%) |
Dec 2014 | -$138.78 M(-47.7%) | -$138.78 M(-16.4%) |
Sept 2014 | - | -$165.94 M(-16.2%) |
June 2014 | - | -$197.98 M(-15.1%) |
Mar 2014 | - | -$233.24 M(-12.1%) |
Dec 2013 | -$265.47 M(-27.9%) | -$265.47 M(-6.7%) |
Sept 2013 | - | -$284.57 M(-9.8%) |
June 2013 | - | -$315.44 M(-8.0%) |
Mar 2013 | - | -$342.72 M(-6.9%) |
Dec 2012 | -$368.30 M | -$368.30 M(-4.8%) |
Sept 2012 | - | -$386.72 M(-5.4%) |
June 2012 | - | -$408.69 M(-6.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | -$439.16 M(-5.7%) |
Dec 2011 | -$465.60 M(-19.0%) | -$465.60 M(-5.5%) |
Sept 2011 | - | -$492.71 M(-3.7%) |
June 2011 | - | -$511.51 M(-5.9%) |
Mar 2011 | - | -$543.83 M(-5.4%) |
Dec 2010 | -$575.16 M(+141.2%) | -$575.16 M(+148.3%) |
Sept 2010 | - | -$231.60 M(+12.1%) |
June 2010 | - | -$206.66 M(-6.5%) |
Mar 2010 | - | -$221.11 M(-7.3%) |
Dec 2009 | -$238.49 M(-30.7%) | -$238.49 M(-6.9%) |
Sept 2009 | - | -$256.06 M(-12.7%) |
June 2009 | - | -$293.38 M(-10.4%) |
Mar 2009 | - | -$327.53 M(-4.9%) |
Dec 2008 | -$344.31 M(-293.9%) | -$344.31 M(-208.4%) |
Sept 2008 | - | $317.57 M(+16.4%) |
June 2008 | - | $272.87 M(+22.5%) |
Mar 2008 | - | $222.68 M(+25.4%) |
Dec 2007 | $177.53 M(+667.8%) | $177.53 M(+26.2%) |
Sept 2007 | - | $140.62 M(+43.7%) |
June 2007 | - | $97.84 M(+63.4%) |
Mar 2007 | - | $59.89 M(+159.0%) |
Dec 2006 | $23.12 M(-70.7%) | $23.12 M(-291.6%) |
Sept 2006 | - | -$12.07 M(-365.8%) |
June 2006 | - | $4.54 M(-121.4%) |
Mar 2006 | - | -$21.21 M(-126.9%) |
Dec 2005 | $78.91 M(-225.1%) | $78.91 M(+177.0%) |
Sept 2005 | - | $28.49 M(-894.6%) |
June 2005 | - | -$3.58 M(-89.9%) |
Mar 2005 | - | -$35.45 M(-43.8%) |
Dec 2004 | -$63.09 M(-58.7%) | -$63.09 M(-24.1%) |
Sept 2004 | - | -$83.17 M(-23.7%) |
June 2004 | - | -$108.99 M(-19.4%) |
Mar 2004 | - | -$135.29 M(-11.5%) |
Dec 2003 | -$152.88 M(-34.4%) | -$152.88 M(-11.9%) |
Sept 2003 | - | -$173.53 M(-10.1%) |
June 2003 | - | -$193.12 M(-9.6%) |
Mar 2003 | - | -$213.68 M(-8.3%) |
Dec 2002 | -$233.04 M(-17.7%) | -$233.04 M(-7.0%) |
Sept 2002 | - | -$250.54 M(-6.9%) |
June 2002 | - | -$269.07 M(-5.7%) |
Mar 2002 | - | -$285.40 M(+0.8%) |
Dec 2001 | -$283.17 M(-11.1%) | -$283.17 M(-3.1%) |
Sept 2001 | - | -$292.08 M(-3.5%) |
June 2001 | - | -$302.61 M(-2.9%) |
Mar 2001 | - | -$311.62 M(-2.2%) |
Dec 2000 | -$318.57 M(+3.7%) | -$318.57 M(-1.4%) |
Sept 2000 | - | -$323.00 M(+8.1%) |
June 2000 | - | -$298.74 M(-2.6%) |
Mar 2000 | - | -$306.71 M |
Dec 1999 | -$307.35 M(-296.9%) | - |
Dec 1998 | $156.11 M | - |
FAQ
- What is Charles River Laboratories International annual retained earnings?
- What is the all time high annual retained earnings for Charles River Laboratories International?
- What is Charles River Laboratories International annual retained earnings year-on-year change?
- What is Charles River Laboratories International quarterly retained earnings?
- What is the all time high quarterly retained earnings for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly retained earnings year-on-year change?
What is Charles River Laboratories International annual retained earnings?
The current annual retained earnings of CRL is $1.89 B
What is the all time high annual retained earnings for Charles River Laboratories International?
Charles River Laboratories International all-time high annual retained earnings is $1.89 B
What is Charles River Laboratories International annual retained earnings year-on-year change?
Over the past year, CRL annual retained earnings has changed by +$454.32 M (+31.71%)
What is Charles River Laboratories International quarterly retained earnings?
The current quarterly retained earnings of CRL is $2.12 B
What is the all time high quarterly retained earnings for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly retained earnings is $2.12 B
What is Charles River Laboratories International quarterly retained earnings year-on-year change?
Over the past year, CRL quarterly retained earnings has changed by +$235.62 M (+12.48%)